Invitae Corp. (NVTA) engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases.
If you look at this from an Elliot Wave point of view the B wave up wicked through the golden ratio (1.618). Over the past 2 years, NVTA has slowly moved down in price. Most recently, based on news that bankruptcy is coming in the coming week price has crashed from .40 to .015. The most interesting part of this is this move down, or the C wave, hit the 3.14 ratio. Lets see if this wicke turns into the 2.618 by the end of the month. According to Elliot, 2.618 is rare for expanded flats, but still an option.
Let's see if NVTA declares bankruptcy in the coming weeks or still has a bit juice still in the tank. To add, largest shareholder CW, has capitulated.
To be continued...
If you look at this from an Elliot Wave point of view the B wave up wicked through the golden ratio (1.618). Over the past 2 years, NVTA has slowly moved down in price. Most recently, based on news that bankruptcy is coming in the coming week price has crashed from .40 to .015. The most interesting part of this is this move down, or the C wave, hit the 3.14 ratio. Lets see if this wicke turns into the 2.618 by the end of the month. According to Elliot, 2.618 is rare for expanded flats, but still an option.
Let's see if NVTA declares bankruptcy in the coming weeks or still has a bit juice still in the tank. To add, largest shareholder CW, has capitulated.
To be continued...